首页
订购/客服:400-666-5481

TBK1/IKKε-IN-5

    
99.80%

TBK1/IKKε-IN-5

源叶(MedMol)
S87655 一键复制产品信息
1893397-65-3
C₂₈H₃₁N₇O₃
513.59
TBK1/IKKε-IN-5
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S87655-1mg买3赠1
99.80%

¥450.00

4 - - - -
S87655-5mg买3赠1
99.80%

¥790.00

8 - - - -
S87655-10mg买3赠1
99.80%

¥1330.00

5 - - - -
S87655-25mg买3赠1
≥98%

¥2450.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: TBK1/IKKε-IN-5 (compound 1) 是一种 TANK-binding kinase 1 (TBK1) 和 IκB kinase-ε (IKKε/IKK-i) 的双重抑制剂,对于TBK1和IKKε的IC50值分别为1.0 nM和5.6 nM。TBK1 /IKKε被抑制可增强对PD-1阻断的反应,从而有效地预测了体内的肿瘤反应
靶点: TBK1(Cell-free assay):1.0 nM; IKKε(Cell-free assay):5.6 nM;IκB/IKK
体外研究: TBK1/IKKε-IN-5(compound 1) effectively blocks immune suppressive cytokine elaboration by CT26 cell line spheroids, without cytotoxic effects, and enhances secretion of IL-2 and IFN-γ from purified CD4+ and CD8+ T cells from healthy human donors and IL-2 from Jurkat human T-cell leukemia cells. Ex vivo addition of TBK1/IKKε-IN-1(compound 1) to PD-1 blockade enhances killing of CT26 MDOTS, associated with decreased levels of CCL4, CCL3, and IL-1β and induction of cytokines involved in activated innate immune responses
体内研究: Balb/c mice bearing CT26 tumors are treated with TBK1/IKKε-IN-1(compound 1) ± anti-PD-L1. Consistent with MDOTS profiling data, greater tumor control and longer survival is evident with TBK1/IKKε-IN-1(compound 1) + anti-PD-L1 than with either TBK1/IKKε-IN-1(compound 1) or anti-PD-L1 alone. Reimplantation of CT26 into mice with exceptional responses to combination therapy shows no growth, whereas EMT-6 implanted tumors grow normally, suggesting induction of immunologic memory of CT26 cells in mice treated with TBK1/IKKε-IN-1(compound 1) + anti-PD-L1. Therefore, MDOTS profiling effectively recapitulates the in vivo response to PD-1 blockade +/− TBK1/IKKε inhibition, highlighting the potential of ex vivo screening in MDOTS to develop combination immunotherapies.
细胞实验: Cell lines: HCT116 cells, human CD4+ T cells, human CD8+ T cells Concentrations: 1 μM Incubation Time: 1 h, 24 h, 96 h Method: Interleukin-2 and interferon gamma analysis—Freshly isolated human CD4+ and CD8+ T cells are spun down and resuspended in serum free X-vivo15 media supplemented with 5 ng/mL IL-17 and incubated overnight at 37°C. Cells are plated on anti-CD3 coated plates with 2 μg/mL anti-CD28. Cells are treated in replicate plates with a dose-titration of TBK1/IKKε-IN-1(compound 1) for 24 hours for IL-2 and 96 hours for IFNγ. IL-2 and IFNγ in the supernatant are measured using single-or multi-plex immunoassay. Jurkat T cell leukemia cells plated on anti-CD3 coated plates are treated with a dose titration of TBK1/IKKε-IN-1(compound 1) for 24 hours.
动物实验: Animal Models: 11-12 week old female Balb/c mice implanted with 1×106 CT26 colon carcinoma cells. Dosages: 40 mg/kg Administration: Oral gavage
参考文献: 1. Russell WJ, et al. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov. 2018 Feb;8(2):196-215.
溶解性: Soluble  in  DMSO
保存条件: -20°C
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.947 ml 9.735 ml 19.471 ml
5 mM 0.389 ml 1.947 ml 3.894 ml
10 mM 0.195 ml 0.974 ml 1.947 ml
50 mM 0.039 ml 0.195 ml 0.389 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×